(Q40222962)

18 September 2017

Synergistic effects of valproic acid and mitomycin C in adenocarcinoma cell lines and fresh tumor cells of patients with colon cancer (English)

1 reference

18 September 2017

Friedmann I

1

1 reference

18 September 2017

Atmaca A

2

1 reference

18 September 2017

Chow KU

3

1 reference

18 September 2017

Jäger E

4

1 reference

18 September 2017

Weidmann E

5

1 reference

18 September 2017

1 August 2006

1 reference

18 September 2017

Journal of Chemotherapy

1 reference

18 September 2017

18

1 reference

18 September 2017

4

1 reference

18 September 2017

415-420

1 reference

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

18 September 2017

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

Histone acetylation and chromatin remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

Tumor selectivity and transcriptional activation by azelaic bishydroxamic acid in human melanocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2006.18.4.415

10.1179/JOC.2006.18.4.415

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference